MedPath

Doxycycline Prophylaxis at Vacuum Aspiration Trial

Phase 4
Completed
Conditions
Endometritis
Interventions
Registration Number
NCT00547170
Lead Sponsor
University of Pittsburgh
Brief Summary

This study is a randomized, double-blinded, controlled trial comparing two regimens of doxycycline for the prevention of infection after surgical abortion. One thousand women undergoing surgical abortion in the first trimester will be enrolled from the clinic at Tu Du Hospital, Ho Chi Minh City, Vietnam. The standard regimen has been 100 mg twice daily for 5 days after the abortion. Subjects will be randomized to the standard regimen or to take 200 mg doxycycline pre-operatively. Subjects found to have a positive Chlamydia EIA test will receive a 7-day course of doxycycline regardless of study group. Subjects will complete questionnaires of symptoms, including nausea and emesis in the recovery room after the procedure and at a single follow-up visit two weeks later. The primary outcome will be infection after abortion, defined below. Analyses will be performed including and excluding Chlamydia-positive subjects. Secondary outcomes will be the proportion with nausea, emesis, and other side-effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1000
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Doxycycline post-operativelyHalf of enrolled women will be randomly assigned to group 2
1Doxycycline pre-operativelyHalf of enrolled women will be randomly assigned to group 1.
Primary Outcome Measures
NameTimeMethod
Infection2 weeks
Secondary Outcome Measures
NameTimeMethod
nausea and emesis2 weeks
compliance (completion of study medication)5 days

Trial Locations

Locations (1)

Tu Du Hospital

🇻🇳

Ho Chi Minh City, Vietnam

© Copyright 2025. All Rights Reserved by MedPath